Visiting Cellink

Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.

We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.

Thank you to Hector Martinez (CTO and Founder, BICO) , Cecilia Edebo (CEO),   Itedale Namro Redwan, PhD (CSO), Elin Pernevik (Biomaterial Scientist), Volodymyr Kuzmenko (Senior Biomaterial Scientist), Patrik Hallberg (CTO) and Niclas Emanuelsson (VP Business Solutions & Sustainability) for the generous hospitality and excellent content.

We look forward to further dissemination of our partnership at TERMIS, Manchester March 28th – 30th.

We look forward to continuing to build out the value that stems from this unique partnership.

Latest News

Visiting Cellink

Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.

We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.

Zoan and partners at TERMIS 2023

Zoan, Cellink and University of Galway collaboration on 3D printable coral-containing bioinks to present results at TERMIS, Manchester, 28-31st March 2023: Biocompatibility of 3D bioprinted tissue model prototypes containing sustainably grown coral skeletal particles for orthopedic applicationsE. Pernevik et. al. Zoan and partners at CELLINK and University of Galway will be presenting the early results from our coral bioink…

Our Sustainability Model

As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…

Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation

Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.

Contact Us

To find out more about Zoan BioMed get in touch